Back to Trials
NCT06935695NARecruiting

Surveillance Versus Bronchoscopy After Airway Stenting

Icahn School of Medicine at Mount Sinai

Start Date

1/1/2025

Completion Date

3/31/2026

Summary

Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting. Exclusion Criteria: * Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment. * Lobar or segmental stents alone * Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy * Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks) * Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)

Interventions

DEVICE

Bronchoscopy

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Bronchial Stents

Locations

The Mount Sinai Health System

New York, New York 10029

United States